Amneal donates over 22 million doses - 10 years of donating medication that saves lives
Enter your search term and press enter. Press Esc or X to close.


Amneal donates over 22 million doses - 10 years of donating medication that saves lives

Amneal Pharmaceuticals has been donating medication to Dispensary of Hope for over a decade now! Their commitment to improving lives starts with producing high quality products and extends far beyond the customers that they serve. They have donated over 22 million doses, medication that is saving and improving lives across the nation. 

“3,000 times every single day a patient who lacks healthcare coverage receives a Dispensary of Hope prescription. A bottle slides across the counter and tears fill a patient's eyes because the amount due rings up as $0.00. This miracle saves lives and delivers freedom for the uninsured and low-income in our nation. Dispensary of Hope focuses on helping the most vulnerable, resulting in improved patient outcomes, as well as reductions in the number of hospitalizations and the overall cost of care. We couldn’t do this without the generosity of Amneal Pharmaceuticals.” Christopher Palombo, CEO, Dispensary of Hope

Dispensary of Hope honors Amneal Pharmaceuticals’ commitment to deliver affordable access to medications–extending that further to donate medications for patients that are uninsured and low income. 

10 years of donations!

“When you’re working with a quality company like Dispensary of Hope–it gives you pride to be part of that, and to be able to make healthy possible for everyone.” Tony Hodges, Vice President of Logistics, Amneal Pharmaceuticals

Amneal’s commitment to help expand access to medication for the most vulnerable has resulted in improved medication access across the majority of the continental United States.
Amneal Pharmaceuticals medication distribution via Dispensary of Hope map:

The Dispensary of Hope model relies on the generosity of partners like Amneal Pharmaceuticals–and they have stepped up to make a difference. This shared commitment to quality and health improvement is measurable. Research from the 2015 Advisory Board Company, and more currently the 2022 RTI International study reveals improvements in health and significant value for the national healthcare landscape. 

Nashville-based Dispensary of Hope has been actively operating and building a national model of medication access for the most vulnerable for over a decade. This innovative model unifies pharmaceutical manufacturing and safety net healthcare delivery with a common goal of saving and transforming lives. The model is unique in its ability to converge different areas of the healthcare industry to provide access to medication at no cost to the patient, while maintaining the highest quality standards in the medication distribution industry. The collaboration delivers pragmatic results including: improved health outcomes for patients, reduced cost and environmental impact from medication destruction and positive shifts in healthcare cost burden from acute care treatment to health condition management. 

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, we’re rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines.

Posted by Matt Blount at 12:58